Atlas Trials

A Multicentre Real-world Study of Heptapopal Ethanolamine Tablets in Concurrent/Sequential Radioimmunoinduced Thrombocytopenia

Clinical trial NCT06376435 · UNKNOWN

Trial details

NCT number
NCT06376435
Sponsor
Hebei Medical University Fourth Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Cancer, Therapy-Related
Start date
2024-04-20
Primary completion
2026-07-01
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.